Guidelines for Diagnosis and Treatment of Cardiac‑Monitor‑Related Contact Dermatitis

Diagnosis and Initial Assessment

Both irritant and allergic contact dermatitis have been reported with any skin‑attached cardiac monitoring device. 1
Isobornyl acrylate is the primary sensitizing component in many adhesive‑related allergic reactions and can produce spreading eruptions beyond the contact site. 1
Clinical morphology alone cannot reliably differentiate allergic from irritant dermatitis; pattern and appearance are not predictive. 3
Key history elements include: timing of symptom onset relative to device placement, whether the rash began at the adhesive site and spread, personal or family history of atopic conditions, and prior reactions to adhesives or topical products. 3
If the rash extends beyond the adhesive footprint, an allergic etiology should be suspected. 3

Discontinue the cardiac monitor when medically feasible; if continuous monitoring is required, rotate the placement site to allow the affected skin to heal. 3
Apply a liberal layer of white soft paraffin or petrolatum to the affected area every 2–4 hours to re‑establish the skin barrier. 2
Ointments are preferred over creams because they contain minimal water and maximal lipid content, offering superior barrier protection. 2
Avoid soaps, fragranced products, and alcohol‑based cleansers on the affected skin; cleanse with plain water or a soap‑free cleanser only. 2

Add a low‑potency topical corticosteroid if marked redness, weeping, or discomfort persists after 3–5 days of optimal barrier therapy. 2
Hydrocortisone 1 % cream or ointment applied twice daily for a maximum of 5–7 days is appropriate for localized reactions. 2
Apply the steroid first, wait 5–10 minutes for absorption, then cover with a barrier ointment. 2

Watch for signs of secondary bacterial infection (crusting, weeping, honey‑colored exudate, pustules) suggestive of Staphylococcus aureus superinfection. 2
If infection is suspected, obtain a bacterial swab and consider a topical antibiotic‑corticosteroid combination or oral antibiotics according to severity. 2

Patch testing is the gold‑standard investigation when allergic contact dermatitis is suspected. 3
Perform patch testing if the rash does not improve after two weeks of appropriate first‑line management. 2
Patch testing demonstrates approximately 70–80 % sensitivity and specificity for confirming allergic contact dermatitis. 4

Periodically inquire about adhesive reactions in device users, as tape formulations may change over time. 1
Identifying and eliminating tape allergens is essential to ensure comfortable device use and promote self‑care. 1
Apply a barrier film or hydrocolloid dressing beneath the monitor adhesive before placement to reduce direct skin contact with potential allergens. 2
Rotate monitor placement sites during prolonged monitoring periods. 3

Do not assume all monitor‑related rashes are simple irritation; allergic contact dermatitis requires allergen identification and avoidance for resolution. 3
Avoid using mid‑ to high‑potency steroids on thin skin (e.g., face, neck, flexural areas) due to the risk of atrophy and telangiectasia. 2
Do not continue the monitor without intervention if dermatitis is worsening; ongoing exposure can lead to sensitization and more severe future reactions. 3